Dutchsinse delivering the goods as usual the last 24hr.
During a live cross it appears he caught clear beams in IR images hitting key fire grounds as they are going:
Long clip of the live session (embedded)
https://www.youtube.com/watch?v=CRPKPJR1k5Q
(short clip showing the beams)
https://www.youtube.com/watch?v=h45dBEq1NyM
Links to the site:
https://weather.cod.edu/satrad/?parms=subregional-Oregon-06-200-0-100-1&checked=map&colorbar=undefined
Presentation from Lt. Col. Thomas Beardens on Russian weather engineering, but also some solid physics discussion on electromagnetics.
Very interdasting.
I just reposted in this bake fren, i saw i drew post 748 so re-dropped.
This DEW shits me, highly suspect of this crap causing the big fires we had here in Aus the last couple years so we feel for our Cali/west coast affected fire bros.
Have worked intimately in aerial firefighting, and the fire behaviour going on the last 2 years is far from 'normal'
Not a chance. Contrails drift, and fire aircraft don't drop at 1am, nor do they fly straight tracks too and from the entire way like that, especially on the drops.
(talking from INTIMATE knowledge of aerial fire opps)
100%, the IR proving to be the best vis via that feed would suggest it should be visible with gogs. The sheer behaviour and nature of these starts is suss.
Also if any anon has a copy of that Agenda21 document that outlined the plans for the changes to suburban areas, and the rail system etc. should use that as a guide for where to look for new starts. Its all related the last couple years.
AstraZeneca Vaccine Tests Face Delay After Patient Gets Ill
Michelle Fay Cortez and Riley Griffin
(Bloomberg) – AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company’s studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19.
The pause stemmed from a standard review of the company’s vaccine trials after one person developed an unexplained illness, AstraZeneca said in a statement. The move was intended to give researchers time to examine safety data while maintaining the integrity of the trials, the company said. The drugmaker’s shares fell as much as 3% in London Wednesday morning. Later, they pared the decline to 1.1% as investors took it in stride as a fairly common event during testing.
The vaccine, which AstraZeneca is developing with researchers from the University of Oxford, has been viewed as one of the leading candidates. The partners are aiming to enroll as many as 50,000 participants for late-stage trials that are underway in the U.K., the U.S., Brazil and South Africa, with others planned for Japan and Russia.
AstraZeneca has a market value of about $140 billion and the largest weighting of all the companies in the U.K.’s FTSE-100 Index.
Shares in Moderna Inc. and BioNTech SE, which are working on rival vaccines, gained in late trading in New York Tuesday.
“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials,” AstraZeneca spokeswoman Michele Meixell said in a statement. She said that it’s too early to determine the sick participant’s specific diagnosis.
https://www.msn.com/en-us/news/world/astrazeneca-vaccine-trials-face-setback-after-patient-gets-ill/ar-BB18PMpV?li=BBnbcA1